173 related articles for article (PubMed ID: 28251899)
1. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
Park YJ; Soh BW; Lee ES
Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
[No Abstract] [Full Text] [Related]
2. Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Matsuda K; Namiki T; Ueno M; Hashimoto T; Hanafusa T; Yokozeki H
Eur J Dermatol; 2017 Jun; 27(3):323-325. PubMed ID: 28414195
[No Abstract] [Full Text] [Related]
3. [A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 May; 30(5):699-702. PubMed ID: 12795105
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced acral erythema due to Tegafur.
Bastida J; Díaz-Cascajo C; Borghi S
Acta Derm Venereol; 1997 Jan; 77(1):72-3. PubMed ID: 9059686
[No Abstract] [Full Text] [Related]
5. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur.
Jucglà A; Sais G; Navarro M; Peyri J
Arch Dermatol; 1995 Mar; 131(3):364-5. PubMed ID: 7887678
[No Abstract] [Full Text] [Related]
6. Eccrine squamous syringometaplasia of underlying syringoma associated with Tegafur/Gimeracil/Oteracil (TS-1).
Kim J; Kim SH; Lee MG; Chung KY; Kim DS
Acta Derm Venereol; 2015 Nov; 95(8):999-1000. PubMed ID: 25766447
[No Abstract] [Full Text] [Related]
7. Interstitial granulomatous drug reaction to sorafenib.
Martínez-Morán C; Nájera L; Ruiz-Casado AI; Romero-Maté A; Espinosa P; Meseguer-Yebra C; Córdoba S; Borbujo JM
Arch Dermatol; 2011 Sep; 147(9):1118-9. PubMed ID: 21931061
[No Abstract] [Full Text] [Related]
8. Images in clinical medicine. Chemotherapy-induced acral erythema.
Pirisi M; Soardo G
N Engl J Med; 1994 May; 330(18):1279. PubMed ID: 8145783
[No Abstract] [Full Text] [Related]
9. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
10. [Dermatologic toxicity to sorafenib].
Velázquez D; de la Cueva P; Zamberk P; Lázaro P
Actas Dermosifiliogr; 2009; 100(6):518-20. PubMed ID: 19709563
[No Abstract] [Full Text] [Related]
11. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
12. Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy.
Revenga Arranz F; Fernández-Durán DA; Grande C; Rodríguez Peralto JL; Vanaclocha Sebastián F
Arch Dermatol; 1997 Apr; 133(4):499-500, 502-3. PubMed ID: 9126025
[No Abstract] [Full Text] [Related]
13. [Blisters unlike others].
Gugerli O; Leupin N
Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
[No Abstract] [Full Text] [Related]
14. Diagnosis in oncology. Hand-foot syndrome.
Jucgla A; Sais G
J Clin Oncol; 1997 Sep; 15(9):3164. PubMed ID: 9312563
[No Abstract] [Full Text] [Related]
15. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
Duh D; Warnez M
J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
[No Abstract] [Full Text] [Related]
16. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
17. Three cases of chemotherapy-induced acral erythema.
Komamura H; Higashiyama M; Hashimoto K; Takeda K; Kimura H; Tani Y; Ogawa H; Yoshikawa K
J Dermatol; 1995 Feb; 22(2):116-21. PubMed ID: 7722086
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.
Komatsu-Fujii T; Ogawa M; Nonoyama S; Fukumoto T; Tanabe H
Eur J Dermatol; 2021 Feb; 31(1):98-99. PubMed ID: 33586655
[No Abstract] [Full Text] [Related]
19. A Rare Case of Reversible Cardiac Dysfunction Associated with Tegafur/Gimeracil/Oteracil (S-1) Therapy.
Oyakawa T; Hua Z; Ebihara A; Shiga T
Int Heart J; 2021 May; 62(3):700-705. PubMed ID: 33994512
[TBL] [Abstract][Full Text] [Related]
20. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur.
Rios-Buceta L; Buezo GF; Peñas PF; Dauden E; Fernandez-Herrera J; Garcia-Diez A
Acta Derm Venereol; 1997 Jan; 77(1):80-1. PubMed ID: 9059693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
